Diagnostic errors currently impact about 12 million Americans, and medical malpractice claims cost over $100 billion annually. AHRQ’s plan comes partly in response to the National Academy of Medicine’s 2015 report Improving Diagnosis in Healthcare, which identified several causes of diagnostic errors, including miscommunication and a lack of transparency in healthcare workplaces.
With the aid of $2 million in Congressional funding, AHRQ will focus its research on what it calls the “Big Three” disease categories linked to half of all diagnostic errors: vascular events, cancer and infection. Research findings can help develop tools that reduce diagnostic errors.
Recent AHRQ research-based strategies include Patient Safety Learning Laboratories, a Health Services Research project, a guide to improving laboratory testing and the AHRQ QuestionBuilder App, which allows patients to prepare questions before appointments to improve diagnosis timing and accuracy.
More articles on clinical leadership and infection control:
7 Heroes of Infection Prevention Award winners honored in Philadelphia
Maggots found in patient’s surgical incision at Hacienda Healthcare
Measles count continues to rise: 4 updates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
